J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 666 INR -2.88% Market Closed
Market Cap: 258.8B INR
Have any thoughts about
J B Chemicals and Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

JBCHEPHARM Price Targets Summary
J B Chemicals and Pharmaceuticals Ltd

Wall Street analysts forecast JBCHEPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 2 027.29 INR with a low forecast of 1 605.9 INR and a high forecast of 2 460.15 INR.

Lowest
Price Target
1 605.9 INR
4% Downside
Average
Price Target
2 027.29 INR
22% Upside
Highest
Price Target
2 460.15 INR
48% Upside
J B Chemicals and Pharmaceuticals Ltd Competitors:
Price Targets
LUPIN
Lupin Ltd
1% Downside
GLENMARK
Glenmark Pharmaceuticals Ltd
3% Upside
603538
Ningbo Menovo Pharmaceutical Co Ltd
57% Upside
ETON
Eton Pharmaceuticals Inc
2% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
11% Upside
ROG
Roche Holding AG
17% Upside
300119
Tianjin Ringpu Bio-Technology Co Ltd
7% Downside
KOTRA
Kotra Industries Bhd
5% Upside

Revenue
Forecast

Revenue Estimate
J B Chemicals and Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 3 years is 14%.

14%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
J B Chemicals and Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 20%. The projected CAGR for the next 3 years is 19%.

20%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
J B Chemicals and Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 17%. The projected CAGR for the next 3 years is 21%.

17%
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JBCHEPHARM's stock price target?
Price Target
2 027.29 INR

According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 2 027.29 INR with a low forecast of 1 605.9 INR and a high forecast of 2 460.15 INR.

What is J B Chemicals and Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 3 years is 14%.

What is J B Chemicals and Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's operating income is 20%. The projected CAGR for the next 3 years is 19%.

What is J B Chemicals and Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for J B Chemicals and Pharmaceuticals Ltd's net income is 17%. The projected CAGR for the next 3 years is 21%.

Back to Top